Key points are not available for this paper at this time.
Myostatin is a novel predictor of aggravated joint destruction in RA patients which has synergistic interaction with myopenia for predicting value.
Share your take
Add a clinician perspective alongside expert commentary.
Lin et al. (Tue,) studied this question.